InvestmentMay 21, 2026, 11:11 AM
Nanobiotix Prices €85M Global Offering at $38.98/ADS
AI Summary
Nanobiotix announced the pricing of its oversubscribed global follow-on offering, expected to generate approximately $98.6 million (€85.0 million) in gross proceeds. The offering includes 225,373 American Depositary Shares (ADSs) at $38.98 per ADS in the U.S., and 1,959,289 Ordinary Shares and 345,099 pre-funded warrants (PFWs) at €33.60 per Ordinary Share and €33.57 per PFW in Europe. The company plans to use the net proceeds to advance its Nanoprimer and other platforms (50-60%), support JNJ-1900 development (less than 10%), and for general corporate purposes (30-40%), extending its cash runway into 2029.
Key Highlights
- Global offering priced to raise approximately $98.6 million (€85.0 million) in gross proceeds.
- U.S. Offering includes 225,373 American Depositary Shares (ADSs) at $38.98 per ADS.
- International Offering includes 1,959,289 Ordinary Shares at €33.60 per share.
- International Offering also includes 345,099 pre-funded warrants (PFWs) at €33.57 per PFW.
- Proceeds to advance Nanoprimer and other platforms (50-60%) and JNJ-1900 development (less than 10%).
- 30-40% of proceeds allocated for general corporate purposes.
- Expected to extend cash and cash equivalents to meet working capital needs into 2029.
- Global Offering expected to close on May 26, 2026.
Price Impact
More from NBTX